ADPT vs AAPL: Which Stock is Better?

Side-by-side comparison of Adaptive Biotechnologies Corp and Apple Inc in 2026

Comparison Updated:

ADPT

Adaptive Biotechnologies Corp

$14.86

AAPL

Apple Inc

$256.90

Key Metrics Comparison

MetricADPTAAPLWinner
Market Cap$2.45BN/AADPT
P/E RatioN/A32.88AAPL
EPS (TTM)$N/A$7.83AAPL
Revenue Growth0.5%0.2%ADPT
Gross Margin74.2%47.3%ADPT

Analyze ADPT

Full quant analysis

Analyze AAPL

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ADPT or AAPL a better investment?

Comparing ADPT and AAPL: Adaptive Biotechnologies Corp has a market cap of $2.45B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ADPT and AAPL?

ADPT (Adaptive Biotechnologies Corp) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ADPT or AAPL?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ADPT or AAPL?

ADPT has higher revenue growth at 0.5% vs 0.2% for AAPL.

Which company is more profitable: ADPT or AAPL?

Adaptive Biotechnologies Corp (ADPT) has higher gross margins at 74.2% compared to 47.3% for AAPL.

Which is the larger company: ADPT or AAPL?

Adaptive Biotechnologies Corp (ADPT) is larger with a market cap of $2.45B compared to N/A for AAPL.

Should I buy ADPT or AAPL in 2026?

Both ADPT and AAPL have investment merit. ADPT trades at $14.86 while AAPL trades at $256.90. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ADPT and AAPL stock?

Key differences: Market Cap ($2.45B vs N/A), P/E Ratio (N/A vs 32.9x), Revenue Growth (0.5% vs 0.2%), Gross Margin (74.2% vs 47.3%).

Popular Stock Comparisons